Results 31 to 40 of about 5,062,336 (201)
Brazilian Journal of Oral Sciences, 2015 Aim: To evaluate the effects of radioiodine therapy on salivary flow in patients with differentiated thyroid cancer. Methods: A sample comprising 88 patients submitted to ablation with iodine 131 was included in the study.
Anna Clara Fontes Vieira +3 more
doaj +1 more source
Clinical Endocrinology, 2019 To compare the efficacy of Radioiodine (RI) and Radiofrequency ablation (RFA) in the treatment of autonomously functioning thyroid nodules (AFTNs). End‐points: nodule volume reduction (NVR) and thyroid function normalization.
R. Cervelli +9 more
semanticscholar +1 more source
Maxillofacial Plastic and Reconstructive Surgery, 2019 Background Radioiodine therapy has been widely used for thyroid disease patients, but hyposalivation and xerostomia may occur in 10~30% of patients. Sialocentesis is a procedure that removes inflammatory substances in the salivary duct and expands the ...
Euy-Hyun Kim +4 more
doaj +1 more source
BMC Cancer, 2019 Thyroid cancer is the most common endocrine malignancy. Some advanced disease is, or becomes, resistant to radioactive iodine therapy (refractory disease); this holds poor prognosis of 10% 10-year overall survival. Whilst Sorafenib and Lenvatinib are now
Sarah R Brown +11 more
semanticscholar +1 more source
Zaporožskij Medicinskij Žurnal, 2021 The aim of this article is to assess the initial status, characteristics of the tumor process and initial surgical treatment in patients with well-differentiated thyroid carcinomas who subsequently showed resistance to 131I therapy, comparing with the ...
M. V. Ostafiychuk +2 more
doaj +1 more source
Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
Zhongliu Fangzhi Yanjiu, 2023 Targeted therapy has brought revolutionary breakthroughs for radioiodine-refractory differentiated thyroid cancer. New targeted drugs have prolonged the survival of patients with advanced differentiated thyroid cancer. Multiple tyrosine kinase inhibitors,
TENG Lisong, XU Zehang, WANG Weibin
doaj +1 more source
Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis
Clinical Endocrinology, 2018 Radioiodine (RAI) is an effective treatment for Graves’ thyrotoxicosis but is associated with a failure rate of 15% and may be a risk factor for thyroid eye disease (TED) and weight gain.
E. Aung +5 more
semanticscholar +1 more source
Predictors of the results of radioiodine therapy of Gagves’ disease
Клиническая и экспериментальная тиреоидология, 2010 The aim of this study was to investigate different clinical and laboratory predictors influence on radioiodine therapy results for Graves' disease. A 1-year prospective study was performed on 621 patients treated with empirical radioiodine therapy.
doaj +1 more source
Uptake and Cytotoxicity Characterization of Radioiodine in MCF-7 and SKBR3 Breast Cancer Cell Lines
Atom Indonesia, 2016 Radioiodine is an effective and low-risk therapy modality in well-differentiated thyroid cancer patients post near-total thyroidectomy. Extra thyroidal tumors such as breast cancer are known to be able to uptake radioiodine.
A. Elliyanti +5 more
doaj +1 more source
Thyrotoxicosis and radioiodine therapy: Does the dose matter?
Indian Journal of Endocrinology and Metabolism, 2012 There are 3 treatment options for thyrotoxicosis: Antithyroid drugs, Surgery and radioiodine. The choice of treatment varies geographically. Radioiodine therapy is preferred in the United States.
Andrew Collier
doaj +1 more source